Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
VK0214, oral TR agonist for X-linked adrenoleukodystrophy (X-ALD) Recent Highlights: In June 2026, Viking announced that its working toward maintenance-dosing data for subcutaneous VK2735 and preparing to start Phase 3 trials of the oral tablet in Q4 2026, with the goal of becoming the first company to offer a dual GLP-1/GIP agonist in both oral and injectable form
This is among the broadest gene-modulatory effects of any known peptide
She's lost 60 pounds so far and calls her results "amazing." "I broke the cycle of all the crazy dieting and yo-yoing," she says
Protects Your Heart Beyond Just Weight Loss GLP-1 medications offer remarkable protection for heart health beyond weight management and blood sugar control
US$ 25.89
US$ 22.41
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 20.27
US$ 29.12
US$ 21.99
